Abstract:Background/Objectives: Optic neuropathies are a category of illnesses that ultimately cause damage to the optic nerve, leading to vision impairment and possible blindness. Disorders such as dominant optic atrophy (DOA), Leber hereditary optic neuropathy (LHON), and glaucoma demonstrate intricate genetic foundations and varied phenotypic manifestations. This narrative review study seeks to consolidate existing knowledge on the genetic and molecular mechanisms underlying ocular neuropathies, examine genotype-phenotype correlations, and assess novel therapeutic options to improve diagnostic and treatment methodologies. Methods: A systematic literature review was performed in October 2024, utilizing PubMed, Medline, the Cochrane Library, and ClinicalTrials.gov. Search terms encompassed "optic neuropathy", "genetic variants", "LHON", "DOA", "glaucoma", and "molecular therapies". Studies were chosen according to established inclusion criteria, concentrating on the genetic and molecular dimensions of optic neuropathies and their therapeutic ramifications. Results: The results indicate that DOA and LHON are mostly associated with the mitochondrial dysfunction resulting from pathogenic variants in nuclear genes, mainly OPA1, and mitochondrial DNA (mtDNA) genes, respectively. Glaucoma, especially its intricate variants, is linked to variants in genes like MYOC, OPTN, and TBK1. Molecular mechanisms, such as oxidative stress and inflammatory modulation, are pivotal in disease progression. Innovative therapeutics, including gene therapy, RNA-based treatments, and antioxidants such as idebenone, exhibit promise for alleviating optic nerve damage and safeguarding vision. Conclusions: Genetic and molecular investigations have markedly enhanced our comprehension of ocular neuropathies. The amalgamation of genetic and phenotypic data is essential for customized medical strategies. Additional research is required to enhance therapeutic strategies and fill the gaps in our understanding of the underlying pathophysiology. This interdisciplinary approach shows potential for enhancing patient outcomes in ocular neuropathies.

Genetic Basis of Pigment Dispersion Syndrome and Pigmentary Glaucoma: An Update and Functional Insights

Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in Its Development.

Updates on the molecular genetics of primary congenital glaucoma (Review)

Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario

Genetics of glaucoma

Association Of Gene Polymorphisms With Primary Open Angle Glaucoma: A Systematic Review And Meta-Analysis

Clinical Characteristics of Pigment Dispersion Syndrome in Chinese Patients.

Exploring Early-Stage Retinal Neurodegeneration in Murine Pigmentary Glaucoma: Insights From Gene Networks and miRNA Regulation Analyses

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Advances in Genetics and Pathogenesis in Primary Open Angle Glaucoma

Lack of Association between LOXL1 Variants and Pigment Dispersion Syndrome/Pigmentary Glaucoma: A Meta-Analysis

Retinitis Pigmentosa: Progress and Perspective

Molecular diagnostics of genetic eye diseases

Recent advances in molecular genetics of primary open angle glaucoma

Clinical and Genetic Analysis of Retinitis Pigmentosa with Primary Angle Closure Glaucoma in the Chinese Population

Progress in Research on Pathogenic Genes of Retinitis Pigmentosa

Insights on the Genetic and Phenotypic Complexities of Optic Neuropathies

Integrating Genetics in Glaucoma Screening

Potential Involvements of Anterior Segment Dysgenesis-Associated Genes in Primary Congenital Glaucoma

Updated Review of Genetic Reticulate Pigmentary Disorders

Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies